Pancreatic Cancer Research

ResearcherUniversity of PittsburghNo recent work listed

Philip Anthony Sutera

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4021-5909; OpenAlex author ID A5008426497. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 3 papers

Papers 3

  1. Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resecta… First author DOI 10.1016/j.prro.2017.10.001↗
  2. Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation. Co-author DOI 10.3389/fonc.2018.00052↗
  3. Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fonc.2018.00282↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dwight Earl Heron · 3 shared papers, 2018 · strength 0.29
  2. Steven A. Burton · 2 shared papers, 2018 · strength 0.17
  3. Herbert J. Zeh · 2 shared papers, 2018 · strength 0.17
  4. Nathan Bahary · 2 shared papers, 2018 · strength 0.17
  5. Kimmen Quan · 1 shared paper, 2018 · strength 0.08
  6. Rodney E. Wegner · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.